The American Diabetes Association Announces Winners of the Innovation Challenge to Transform Diabetes Care
This challenge Kickstarts additional investments through the new ADA Innovation Fund
CHICAGO, June 21, 2025 /PRNewswire/ -- As the American Diabetes Association® (ADA) celebrates its 85th anniversary, it continues to fuel transformative progress in the fight to end diabetes—and increasingly, obesity. This year's Innovation Challenge, held during the ADA's 85th Scientific Sessions, highlighted bold ideas driving the future of diabetes treatment and support.
Five visionary finalists presented their innovations on the main stage before a panel of expert judges and a live audience. Three outstanding winners were selected for their potential to revolutionize diabetes care: Kihealth, MYNERVA, and Kayothera, INC.
'One of the biggest things we've learned in our 85 years is that in the fight to end diabetes, every new bit of knowledge, every advancement in treatment, every novel idea matters. We're proud to support these innovators as they help shape a future free of diabetes and all its burdens,' said Elle Uh, the ADA's chief strategy officer and chief of staff.
This year's winners and finalists included:
Winner: Kihealth—A diagnostic test to measure the rate of beta cell death through a liquid biopsy, providing patients and clinicians with a clear view of metabolic health and an earlier window into disease development.
Winner: MYNERVA—An AI-driven neuroprosthetic smart sock for diabetes-related neuropathy to reduce pain and regain stability.
Winner: Kayothera, INC—A first-in-class antagonist of the undruggable retinoid pathway to treat and potentially reverse type 2 diabetes.
Finalist: BioDynamik, Inc.—An orthopedic-driven angiogenesis to restore perfusion for the healing of recalcitrant ischemic ulcers.
Finalist: Generated Health—A chatbot combining AI-driven automation and human-like empathy with a simple text-based platform designed to support both patients and health care teams.
The Innovation Challenge occurs at a critical time. Over 38 million Americans live with diabetes and about 125 million live with obesity. To meet these interconnected epidemics head-on, the ADA is launching the ADA Innovation Fund, a venture philanthropy fund designed to advance the ADA's mission by investing in innovative, high-impact companies developing diabetes, obesity, and other comorbidity-related solutions. Leveraging the ADA's 85-year history of funding hundreds of millions of dollars in innovative research grants, these investments aim to continue to accelerate mission-critical scientific breakthroughs, reduce health disparities, and promote sustainable health care solutions.
About the ADA's Scientific Sessions
The ADA's 85th Scientific Sessions, the world's largest scientific meeting focused on diabetes research, prevention, and care, will be held in Chicago, IL, on June 20–23. Thousands of leading physicians, scientists, and health care professionals from around the world are expected to convene both in person and virtually to unveil cutting-edge research, treatment recommendations, and advances toward a cure for diabetes. Attendees will receive exclusive access to thousands of original research presentations and take part in provocative and engaging exchanges with leading diabetes experts. Join the Scientific Sessions conversation on social media using #ADASciSessions.
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure—and we're not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we're fighting for them all. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook ( American Diabetes Association ), Spanish Facebook ( Asociación Americana de la Diabetes ), LinkedIn ( American Diabetes Association ), and Instagram ( @AmDiabetesAssn ). To learn more about how we are advocating for everyone affected by diabetes, visit us on X ( @AmDiabetesAssn ).
View original content to download multimedia: https://www.prnewswire.com/news-releases/the-american-diabetes-association-announces-winners-of-the-innovation-challenge-to-transform-diabetes-care-302487719.html
SOURCE American Diabetes Association
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
29 minutes ago
- CBS News
Thousands of kids take part in T.D. Jakes Foundation STEAM Expo
Thousands of children and families gathered Saturday at the Shops at RedBird for the T.D. Jakes Foundation's second annual STEAM Expo, a hands-on event designed to spark curiosity and creativity in science, technology, engineering, arts and math. Hands-on learning inspires young minds Excited lines of kids and parents streamed into the venue, where they explored interactive booths, live demonstrations and family-friendly activities. Topics ranged from human anatomy and artificial intelligence to sports medicine and forestry. Five-year-old Leondri Stiggle was especially enthusiastic about the science experiments. "It feels hot, so hot! We made lotion, and it feels like it's juice," she said. Her father, Leon Stiggle, said he wished he had access to similar opportunities as a child. "When you start early, it always evolves into something better," he said. "It's good they have this program — shout out to T.D. Jakes. Appreciate it!" Juneteenth education adds cultural depth The event also featured educational exhibits on Juneteenth, including live actors portraying historical figures such as Fort Worth's Dr. Opal Lee, known as the "grandmother of Juneteenth." The Southwest Dallas County Alumnae Chapter of Delta Sigma Theta Sorority Inc. sponsored the exhibit. "We also have other living exhibits where you can learn about the Emancipation Proclamation and educational development," said chapter president Maiya Bangurah. Building a future-ready workforce Kelley Cornish, president of the T.D. Jakes Foundation, said the expo marked the nonprofit's 10th pop-up event in two years. "People don't realize what an incredible field this is," Cornish said. "We've learned that 2.4 million jobs go unfilled every year because there's no pipeline. We're starting early. Exposure to these careers can literally change a family's dynamic." The foundation's next event is scheduled for the fall.
Yahoo
33 minutes ago
- Yahoo
Check Your Freezer—FDA Announces Potentially Life-Threatening Recall of Popular Ice Cream
Summer is just around the corner and ice cream is the quintessential warm weather treat. But if you have a carton or two chilling in your freezer, you might want to check the label. Breyers recently issued a recall on 6,668 cases of ice cream due to "undeclared allergens and mislabeled product." According to the FDA, the voluntary recall was initiated on June 2 because Breyers Rocky Road, which contains the almonds, was packaged incorrectly. The ice cream was packaged in Breyers Chocolate Truffle tubs with Rocky Road lids, which may be a concern for anyone who purchased the product and has a nut allergy. While almonds are a tree nut, the Chocolate Truffle tubs offer misleading ingredient information. The tubs say "may contain tree nuts" while the lids say "contain almonds." The FDA classified the recall as a Class II, which is defined as "a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." So how do you know if your ice cream is affected? Take a peek at the packaging of your Breyers ice cream tub. Affected products have the lot number: JUL1026GB3 and UPC code: 077567457288. In a statement to PEOPLE, Breyers says: "People with an almond allergy should not consume the product due to risk of serious or life-threatening allergic reaction. The safety and quality of our products is our top priority. For more information, consumers can visit or call 1-800-931-2826." You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
Yahoo
34 minutes ago
- Yahoo
Hunting for the next Tesla-style stock? This might help…
The gains that early Tesla stock investors generated are legendary. Since going public in 2010, Tesla has gone up by around 25,000%, turning every $5,000 invested into more than $1m! In the early years, Tesla's ambition to shake up the car industry was seen by most as fanciful, at best. But driven forward by its very unconventional CEO Elon Musk, it went on to become a $1trn company. Unfortunately, I didn't invest in Tesla back in the early days. But I've noticed a similar thread of unconventionality running through many of my best stock investments. Take Axon Enterprise, for example, which is my largest holding after rocketing 750% in the past five years. The company's mission? To make the bullet obsolete (through its Tasers). Not exactly a traditional corporate goal! Axon's focus on solving customers' problems is relentless. CEO Rick Smith once hosted a live quarterly earnings call from the back seat of a police car, while out on patrol with a law enforcement customer. That was quirky. Or consider Games Workshop from the FTSE 100. It does no acquisitions or earnings calls with analysts focused on the next quarter. No rah-rah investor updates. Just a laser focus on one niche goal: to make the best fantasy miniatures in the world, profitably, forever. One of my newer holdings – Nu Holdings – is a digital bank in Latin America. It launched its purple credit cards across Brazil precisely because purple was considered the most 'anti-bank' colour possible. I like that disruptive mentality. This brings me to Duolingo (NASDAQ: DUOL), the world's most downloaded language-learning app, which I invested in a few months ago. The firm's mission is to 'develop the best education in the world and make it universally available'. It made great strides towards that goal in Q1, which saw daily active users soar 49% to 46.6m. Revenue jumped 38% to $230.7m, while net profit rose to $35.1m, from $27m. As one of those daily active users (and a paid subscriber), I can testify to what Duolingo calls its 'healthy dose of weirdness'. This includes a motley cast of cartoon characters and unhinged social media campaigns. And the app's mascot, a peculiar green owl, which sends learners guilt-tripping push notifications. In November, Duolingo really cranked up the quirkiness when Lily — its sassy artificial intelligence (AI)-powered, emo teenage character — actually opened the company's earnings call with Wall Street analysts. That was a first, but exactly the sort of thing I like to see! Duolingo's stock isn't cheap, and it's facing potential competition from Google, which is a big risk to be aware of. But it has all the hallmarks of a winning investment to me, and I think it's worth considering for long-term investors, especially on dips. We are willing to be misunderstood for long periods of time. These quirks might sound irrelevant. And they obviously don't show up on the balance sheet or income statement. But I believe they're a big part of why some growth companies are wildly successful. So this is something I specifically like to see in most of the growth companies I invest in. Something distinctive about the firm or its corporate culture. After all, unusually good returns will rarely be delivered by average companies. The post Hunting for the next Tesla-style stock? This might help… appeared first on The Motley Fool UK. More reading 5 Stocks For Trying To Build Wealth After 50 One Top Growth Stock from the Motley Fool John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Ben McPoland has positions in Axon Enterprise, Duolingo, Games Workshop Group Plc, and Nu Holdings. The Motley Fool UK has recommended Amazon, Axon Enterprise, Duolingo, Games Workshop Group Plc, Nu Holdings, and Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. Motley Fool UK 2025
